Bilateral Pallidal Deep Brain Stimulation Controls Dystonia in X-Linked Dystonia-Parkinsonism
Investigators examine the long-term outcomes of pallidal deep brain stimulation in x-linked dystonia-parkinsonism.
All articles by Hannah Dellabella
Mortality Rates in Parkinson Disease Psychosis With Pimavanserin, Quetiapine
In patients with Parkinson disease psychosis, treatment with pimavanserin has a lower risk for mortality compared with quetiapine or combination therapy.
Guideline for Diagnosis and Treatment of Idiopathic Intracranial Hypertension
The European Headache Federation has issued recommendations on how to best diagnose and treat idiopathic intracranial hypertension.
New Dyspnea Assessment Developed for Amyotrophic Lateral Sclerosis
The novel questionnaire may identify patients with ALS suffering from dyspnea and allow early assessment and monitoring for symptom management.
Lasmiditan May Be Effective as Acute Migraine Treatment
Lasmiditan was found to be more effective compared with placebo in eliminating pain and other symptoms associated with headache in individuals with migraine.
Anxiety Without Comorbid Depression Associated With Less Risk for Falls in MS
Investigators examined the involvement of depression and anxiety on cognition and falls in patients with multiple sclerosis.
Abdominal Muscles, Disease Onset Predict Efficacy of Subthalamic Nucleus DBS in Parkinson’s
Investigators sought to determine whether subthalamic nucleus deep brain stimulation could influence clinical outcomes in patients with Parkinson disease.
Low Cerebrospinal Fluid Amyloid Beta Levels Predict MS Disease Progression
A cerebrospinal fluid Aβ level may be a predictive biomarker for multiple sclerosis progression.
Abbreviated Apathy Evaluation Scale Consistent, Effective in Parkinson Disease
The Apathy Evaluation Scale was shorted to two-thirds of the original length and investigators evaluated the validity in Parkinson disease.
Age, Number of Relapses Predict Increasing Disability in Multiple Sclerosis
Investigators examine identifiers to predict disability in patients with relapsing-onset multiple sclerosis.
- Loading...
Loading...
Next post in Multiple Sclerosis Advisor
Loading... 
Loading...